Italfarmaco Group Announces New PDUFA Date for Givinostat DMD NDA
29 Nov 2023 //
BUSINESSWIRE
Italfarmaco Completes FDA Submission of NDA for Givinostat in DMD
29 Jun 2023 //
BUSINESSWIRE
Italfarmaco Group Announces Positive Topline Data from PIII Trial of Givinostat
25 Jun 2022 //
BUSINESSWIRE